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Conclusions: Progenitor cell proliferation in the embryo is limited by
environmental factors, not a cell-intrinsic mechanism. The linear
relationship between PDGF supply and final cell number strongly suggests
that cells deplete the mitogenic activity in their environment at a rate
proportional to the total number of cells. The cells might simply consume
the available PDGF or they might secrete autocrine inhibitors, or both.
Background and third as it is known that the major mitogen for these
cells in vivo is platelet-derived growth factor (PDGF),The ultimate size of an organism is determined by the
number of cells that develop in its various tissues and the biochemistry of which is relatively well understood.
organs. Cell numbers are determined by the combined
We previously reported that the oligodendrocyte progeni-effects of cell proliferation, differentiation, and long-term
tor cell cycle slows down markedly as their numbers in-survival, each of which is regulated by interactions be-
tween cells and their local environment. We do not have crease in the embryonic spinal cord [3]. This behavior
is common to other types of embryonic precursors. Fora clear idea of how these controls, which operate on indi-
vidual cells, are integrated at a population level to deliver example, the division cycle of pluripotent precursors in
the embryonic rat cerebral cortex slows from z8 to z24 hrthe appropriate final number and density of cells. It is
possible that each cell has an inbuilt limit on the number during cortical neurogenesis [4]. Determining the cause
of this dynamic cell cycle behavior will be crucial forof replicative cycles it can undergo or the length of time
it can remain in cycle, and cells automatically stop dividing understanding how final cell number is controlled during
development.and differentiate when they reach this limit. Alternatively,
the limit could be set by the amounts of mitogenic or
We show here that if spinal cord cells are dissociated andantiproliferative factors in the local environment [1, 2].
cultured in the presence of saturating concentrations of
PDGF, the oligodendrocyte progenitor cells cycle rapidlyWe are trying to understand how cell numbers are con-
trolled by studying a population of neural progenitor cells irrespective of how slowly they were cycling in vivo prior
to dissociation. Therefore, the mechanism that causes thethat gives rise to oligodendrocytes, the myelin-forming
cells of the central nervous system (CNS). Oligodendro- progenitor cell cycle to slow down in vivo is not cell
intrinsic, but rather involves a change in the extracellularcyte progenitors are amenable to studies of proliferation
control, first because there are lineage markers that allow environment of the developing CNS. By manipulating
PDGF expression in the spinal cords of transgenic mice,them to be visualized and counted in situ, second because
they can be grown, labeled, and counted readily in vitro, we show that the upper limit on progenitor cell number
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Figure 1is set in direct proportion to the level of PDGF transcripts
(rate of production of PDGF). The linear range extends
from practically no PDGF expression (in PDGF-A null
mice) to many times normal (in transgenic PDGF-A over-
expressers) with no sign of impending saturation. The
simplest explanation is that no matter what the rate of
PDGF production, cells proliferate until the PDGF sup-
ply becomes limiting. When the rate at which cells con-
sume PDGF approaches the rate of supply, competition
for PDGF intensifies and its extracellular concentration
drops, causing the cell division cycle to slow down and
preventing a further increase in cell number.
Results
The oligodendrocyte progenitor cell cycle slows
down markedly before birth
In the rodent spinal cord, oligodendrocyte progenitors
can be visualized by immunohistochemistry and/or in situ
hybridization for PDGF a receptors (PDGFRa) and the
proteoglycan NG2 [5–7]. PDGFRa-positive progenitors
first appear in the ventral neuroepithelium near the floor
plate on embryonic day 12.5 (E12.5) in the mouse [3].
Subsequently, they proliferate and migrate throughout
Cumulative BrdU labeling of embryonic oligodendrocyte progenitorsthe cross section of the cord before differentiating into
in vivo. (a) E13 and E17 mouse embryos were BrdU labeled byoligodendrocytes. We previously conducted a cumulative
implanting an osmotic minipump in the mother. After the desired time,
BrdU-labeling study in vivo and concluded that the cell embryonic spinal cord cells were dissociated, cultured overnight, and
division rate of oligodendrocyte progenitors slows down immunolabeled for NG2 proteoglycan and BrdU. The BrdU labeling
index was plotted against time. Total cell cycle time (Tc) and S phasedramatically (from z8 to z24 hr) between E13 and birth
time (Ts) were calculated from the line of best fit and are depicted[3]. We have now repeated that study and confirm the
graphically. In this and subsequent figures, the total length of the
general conclusion that cell division slows down. We arrow represents Tc and the block of solid color represents Ts. The
found, however, that our previous cell cycle times were cells cycle more than three times slower at E17 than at E13. (b)
Comparison of methods for calculating the oligodendrocyte progenitorseriously underestimated. We found instead that the pro-
labeling index after BrdU labeling in vivo. Top panel: dissociatedgenitor cell cycle slows from z30 to z100 hr within the
spinal cord cells were cultured overnight and immunolabeled with anti-
same period (Figure 1; see Materials and methods for NG2 and anti-BrdU. Arrows show two (NG21, BrdU1) progenitors.
details). There are methodological differences between Middle and bottom panels: a transverse section of an embryonic spinal
cord was subjected to in situ hybridization with a probe against PDGFRathis and our earlier study, notably the use of osmotic
followed by immunodetection of BrdU. Immunofluorescenceminipumps rather than sequential injections for BrdU
micrographs are superimposed on the corresponding in situ
delivery. In trial experiments, however, we found that both hybridization images. Arrows in the bottom panel show two
methods yielded comparable results. We also compared (PDGFRa1, BrdU1) progenitors. The cell culture method and the
in situ method gave similar BrdU labeling indices, so the simpler culturethe following two methods of scoring BrdU-labeled progen-
method was used for all experiments reported in this paper. The scaleitors: combined BrdU immunodetection and PDGFRa in
bars represent 10 mm (top and bottom) and 100 mm (middle).situ hybridization on tissue sections, and double immuno-
labeling for BrdU and NG2 in dissociated cell cultures
(Figure 1). Again, both methods gave comparable data.
taining BrdU (10 mM) and a saturating amount of recombi-Therefore, while we do not fully understand the reasons
nant PDGF-AA (10 ng/ml). After various times in vitro, wefor our earlier error, we are confident that our revised
fixed the cells and immunolabeled them with antibodies(longer) cell cycle estimates are reliable, and should super-
against BrdU and NG2 to visualize progenitors that hadsede those of Calver et al. (see Discussion) [3].
undergone DNA synthesis in culture. We could distin-
guish E13 and E17 cells in the mixed cultures becauseSlowing of the cell cycle reflects a changing mitogenic
environment in vivo we prelabeled one of the populations with a fluorescent
We asked whether the slowdown in the cell cycle noted membrane-permeable dye (CFSE, Molecular Probes) be-
above resulted from an intrinsic change in the mitogenic fore plating (Figure 2). These cumulative BrdU-labeling
responsiveness of progenitor cells or, alternatively, a change experiments showed that there is no intrinsic difference
in their extracellular environment. We dissociated spinal between E13 and E17 cells in their mitogenic response
cord cells from E13 and E17 mice and placed them in to saturating PDGF in vitro and that both populations
of progenitors cycled much faster in vitro, in saturatingculture, either separately or mixed, in a medium con-
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Figure 2 Figure 3
PDGF concentration controls progenitor cell cycle time in vitro. Spinal
cords from E18 embryos were dissected and cultured overnight in
10 ng/ml or 1 ng/ml PDGF-AA. BrdU was added and the cumulative
labeling index was determined. The oligodendrocyte progenitor cell
cycle was significantly longer at 1 ng/ml than at 10 ng/ml PDGF.
Variation was largely in the G2-M-G1 phases of the cycle.
PDGF, than they did in vivo prior to dissociation (Figure
2). We conclude from the latter observation that PDGF
is limiting for cell division in vivo at both E13 and E17.
There might also be an inhibitory activity in vivo that is
lost when the cells are placed in culture. The reason the
cell cycle slows down in vivo between E13 and E17 is not
because the cells’ inherent ability to respond to mitogens
decreases, but because there is less mitogenic activity in
the extracellular environment. That is, the PDGF concen-
tration falls and/or a putative inhibitory activity rises.
Progenitor cell cycle time depends
on PDGF concentration
To test the principle that a falling PDGF concentration
might slow the progenitor cell cycle in vivo, we measured
the cell cycle time of E18 progenitor cells cultured inCumulative BrdU labeling of oligodendrocyte progenitors in vitro. (a)
Dissociated E13 spinal cord cells were prelabeled with the either 10 ng/ml or 1 ng/ml PDGF. In both saturating
fluorescent dye CFSE (see Materials and methods) before they were and subsaturating PDGF concentrations, the progenitors
mixed with unlabeled E17 cells and cultured overnight. BrdU was
behaved as uniform populations of cycling cells; the pro-then added for various times before fixing and immunolabeling with
portion of BrdU-labeled cells increased linearly with timeanti-NG2 and anti-BrdU. The CFSE and fluorescein signals are both
green, but can be distinguished because CFSE is in the cytoplasm until almost all of the cells were labeled (Figure 3). The
whereas NG2 is on the cell surface. Numbered cells: (1) an (NG21, cell division rate depended on PDGF concentration, how-
BrdU2, CFSE2) E17 progenitor, (2) an (NG21, BrdU1, CFSE1) E13
ever. In 10 ng/ml PDGF, the cell cycle time was 21 6progenitor, and (3) an (NG21, BrdU1, CFSE2) E17 progenitor. The
scale bar represents 10 mm. (b) The BrdU labeling index was plotted 1 hr, whereas in 1 ng/ml PDGF it was 29 6 2 hr (Figure 3).
against time for E13 and E17 cells (see key) in mixed-age cultures Even the latter time is much shorter than is observed in
(left graph) and separate cultures (right graph). Tc and Ts were vivo at E17 (100 6 17 hr), suggesting that the effectivecalculated from the lines of best fit and are shown graphically. The
PDGF concentration might fall significantly below 1 ng/in vivo labeling data from Figure 1 are also shown for comparison.
Points that appear to be on the plateau were not included when ml in vivo. In any case, this experiment demonstrates that
calculating the line of best fit. There is no significant difference between the falling cell division rate in vivo could potentially be
the cell cycles of E13 and E17 cells, unlike the situation in vivo. caused by a dwindling PDGF concentration. Note thatNote also that the division rate is speeded up in vitro compared to
the length of S phase was not affected by the PDGFin vivo for both E13 and E17 cells.
concentration in vitro, consistent with previous studies
on cultured fibroblasts. A similar dependence of cell cycle
time on PDGF concentration was also observed for E14
progenitors (data not shown).
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Figure 4Cell number is controlled by the PDGF supply
in a linear, unsaturable fashion
Cell-intrinsic mechanisms do not appear to be responsible
for limiting progenitor cell number during normal embry-
onic development (see previous two paragraphs). It might
be expected that there would be some inbuilt limit on
proliferation as a fail-safe device, however, in case mito-
genic activity in the environment were deregulated some-
how during development or neoplasia. We imagined that
a cell-intrinsic mechanism would kick in to halt cell divi-
sion if we were to induce extreme hyperproliferation of
progenitor cells by elevating PDGF expression beyond
some critical point in vivo. We tested this idea by overex-
pressing PDGF in transgenic mice.
We previously described a line of transgenic mice that
expresses human PDGF-A in the CNS under the control
of the neuron-specific enolase promoter (NSE-PDGF-A
mice) [8]. This line (#75) developed greater than normal
numbers of oligodendrocyte progenitors in the spinal cord,
approximately three times more in hemizygotes and seven
times more in homozygotes [3]. The cell cycle slowed
down and the cell number reached a stable upper limit
(steady state) just as in wild-type mice, except that the
PDGF overexpression in transgenic mice delays slowing of the
final cell number and density were higher in the trans- progenitor cell cycle in vivo. E13 and E17 embryos from wild-type
genics. Cell division was faster in the transgenics at early (wt) female mice mated with hemizygous NSE-PDGF-A transgenic
(line #75) males were BrdU labeled in vivo. Spinal cord cells fromtimes (E13), accounting for the greater number of cells
each embryo were dissociated and cultured individually on coverslips.at steady state (Figure 4) [3]. At later times (E17) however, The embryos were genotyped retrospectively. Each data point represents
cell division in the transgenics slowed to the same rate the mean 6 SD for at least three and up to six embryos. Asterisks (*)
mark data points for which the difference between wild type andas the wild type (Figure 4) [3]. This suggests that the
#75 is statistically significant (Student’s t test; p , 1026). The dataextracellular PDGF concentration at steady state is the
show that transgenic progenitors cycle faster than wild-typesame in the transgenics as in the wild type. This might progenitors at E13. By E17, the division cycle slows down to
seem counterintuitive, but it must be borne in mind that approximately the same rate (z70 hour cycle) in both wild-type and
transgenic mice, however. Tc and Ts, estimated from lines of best fit,the transgenics express not only more PDGF, but also
are illustrated graphically.more PDGF receptors (because they have more progeni-
tor cells), introducing the idea that progenitor cell prolifer-
ation might always be limited by the relative rates of
PDGF supply and demand (see Discussion).
relationship between PDGF-A and PDGFRa transcript
levels (Figure 5b). Because we showed that PDGFRaWe increased PDGF expression still further by inter-
transcript levels accurately reflect the number ofbreeding line #75 with another line of NSE-PDGF-A mice
PDGFRa-expressing cells (see Figure 7 and Materials(#82) to generate offspring with up to four PDGF-A trans-
and methods), we conclude that cell number is directlygene loci in addition to their two endogenous genes. Our
proportional to PDGF-A expression over the full range ofbreeding regimen could possibly have generated nine dif-
genotypes examined. This unexpected result is explicableferent genotypes of which we found eight (Figure 5). We
only if PDGF-A mRNA abundance directly determinesvisualized PDGF-A expression by in situ hybridization
the rate of synthesis and secretion of the PDGF-A protein,with a human cDNA probe that binds both endogenous
which in turn determines the number of progenitor cells(mouse) and transgenic (human) PDGF-A transcripts. In
at steady state. It is striking that there is no obvious signparallel, we visualized oligodendrocyte progenitor cells
of the PDGF dose–response plot approaching saturationwith a probe against mouse PDGFRa. By eye, there ap-
in vivo (Figure 5b). Therefore, there appears not to bepeared to be a close correlation between the abundance
any cell-intrinsic limit on proliferation even when the cellof PDGF ligand and receptor transcripts at E15, even at
number is amplified more than 10-fold (Figure 5a). Atthe highest levels of PDGF-A expression (Figure 5a). We
this extreme, the mice displayed spinal curvature andquantified mRNA abundance in newborn mice by RNase
vertebral deformities, and did not survive the first postna-protection (see Materials and methods) and confirmed
this visual impression; there was an approximately linear tal week [9].
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Figure 5
Progenitor cell number in newborn mice is proportional to the PDGF quantified in newborn mice by RNase protection. PDGFRa transcript
supply. (a) Spinal cord sections of E15 wild-type and transgenic levels provide an accurate reflection of the number of PDGFRa-
NSE-PDGF-A mouse embryos with the genotypes shown were positive cells (see Figure 7). The relative amount of endogenous
subjected to in situ hybridization with probes against PDGFRa and PDGF-A was estimated in a separate experiment (data not shown)
PDGF-A. To allow a fair comparison of the sections, in situ hybridization to be equivalent to the contribution from one transgenic allele (#75).
reactions were carried out at the same time and photographed under This was added to each transgenic contribution before plotting total
identical conditions. The numbers of PDGFRa1 progenitor cells rise in PDGF-A versus PDGFRa (normalized to wt 5 1). The dose response
parallel with PDGF-A expression, even at the highest levels of expression. is approximately linear (correlation coefficient R 5 0.85). Thus,
The scale bar represents 150 mm. (b) mRNAs encoding mouse progenitor cell number is directly proportional to the rate of PDGF
PDGFRa and transgene-derived human PDGF-A (hPDGF-A) were supply, even at very high levels of PDGF overexpression.
We also examined the effect of reducing mitogen expres- hybridization images rather than indirectly by PDGFRa
mRNA abundance as in Figure 5. This confirms and rein-sion in PDGF-A knockout mice [10]. As reported before
forces the conclusion that cell number and PDGF supply[3, 11], homozygous knockouts had very few PDGFRa-
are directly proportional.expressing progenitor cells in their spinal cords (,10%
normal). Heterozygous PDGFRa knockouts had close to
half the normal number (Figure 6). Therefore, the linear Discussion
relationship between PDGF-A expression and the final Progenitor cell cycle dynamics and final cell number
cell number holds for reduced as well as for elevated levels is controlled by the environment
of PDGF expression (Figure 6). Note that progenitor cell One of the main conclusions of this work is that progenitor
densities were sufficiently low in the sections of Figure cell cycle dynamics (that is, the deceleration of the cycle
observed as the embryo ages) is controlled by the extracel-6 that they could be counted directly from the in situ
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Figure 6
Progenitor cell number is proportional to
the PDGF supply. The linear relationship
between PDGF-A and final cell number also
holds when PDGF is underexpressed in PDGF-A
knockouts. (a) Spinal cord sections of E15
mouse embryos hybridized in situ to a
PDGFRa probe: homozygous PDGF-A
knockout (2/2), heterozygous PDGF-A
knockout (1/2), wild type (wt), hemizygous
NSE-PDGF-A (75), and homozygous NSE-
PDGF-A (75/75). Progenitor cell numbers rise
with increasing levels of PDGF-A expression.
The scale bar represents 100 mm. (b) Total
PDGF-A mRNA level was estimated by
RNase protection and plotted against the
number of PDGFRa progenitors counted by
eye in photographic enlargements of the in situ
micrographs. The amount of functional
PDGF-A mRNA was assumed to be zero in
(2/2) embryos and half of normal in (1/2)
embryos, since our RNase protection assay
could not distinguish wild-type from
nonfunctional, hybrid PDGF-A-neo transcripts
in the knockouts. The dose response is linear
(correlation coefficient R 5 0.99). Taken
together with Figure 5, we conclude that
progenitor cell number is directly proportional
to PDGF supply over a range of expression
levels from near zero (PDGF-A null) to more
than ten times normal (75,82/75,82 transgenic).
lular environment. This follows from our observation that PDGF transcript levels (which we take to be an indicator
of the rate of PDGF synthesis and secretion) over a widethe cell division rates of E13 and E17 progenitors were
indistinguishable in vitro in saturating PDGF, even range of PDGF expression. This is perhaps counterintu-
itive, being that mitogen dose–response curves in vitrothough their division rates in vivo were very different.
Slowing of the cell cycle is accompanied by a decline in are typically sigmoidal in shape, rising from background
to maximal (plateau) response over a limited range ofthe rate of increase of progenitor cell number, so that the
cell number reaches a plateau before birth and remains concentrations, about a 10-fold range for oligodendrocyte
progenitors and PDGF [12]. In vitro dose responses, how-stable for some time after birth. It seems likely that cell
cycle dynamics directly influence the final cell number ever, usually record rate of cell division versus mitogen
concentration, whereas our in vivo dose response reflectsand therefore that the cell number is controlled by the
environment, not by a cell-intrinsic counting mechanism. final cell number versus rate of production of mitogen. We
do not know what the effective PDGF concentration isThis does not mean that the intracellular state of cells
stays constant during embryogenesis, but that any intrin- in vivo except that it is limiting (subsaturating).
sic changes that might limit the proliferation rate are prob-
It should be possible to estimate the effective concentra-ably a consequence of the changing mitogenic environ-
tion of PDGF from the measured cell cycle time in vivo,ment outside the cell and remain reversible, at least for
given that cell cycle time seems to be predictably relateda few days (between E13 and E17).
to the PDGF concentration in vitro (Figure 3). At E13,
cell cycle time in vivo was comparable to that measuredThe progenitor cell population in the embryonic cord can
be expanded seemingly without limit, simply by increas- in vitro in the presence of 1 ng/ml PDGF-AA (z30 hr).
Cell cycle time at E17 in vivo was z100 hr, however,ing the rate of supply of PDGF. This strongly supports our
conclusion that the only effective constraint on progenitor suggesting that the effective PDGF concentration is much
less than 1 ng/ml by that time. We have not recapitulatedcell number in the embryonic cord is the extracellular
mitogen supply, and raises the question of whether pro- a 100-hour cycle in vitro, because in very low concentra-
tions of PDGF the cells tend to drop out of divisiongenitor cells would proliferate indefinitely in vivo if an
inexhaustible supply of PDGF could be provided. We and differentiate, as they do in the complete absence
of PDGF. It would be interesting to see whether thecould not approach this condition because higher levels
of PDGF caused spinal deformity and killed the animals. combination of a low concentration of PDGF together
with fibroblast growth factor, which is known to inhibitIt is striking that cell number is directly proportional to
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oligodendrocyte differentiation in vitro [13], would be simple model explains the linear relationship between the
rate of PDGF supply and the final cell number (Figures 5able to keep progenitors dividing slowly in vitro. Omitting
thyroid hormone from the medium might also help [14]. and 6). It also explains why the cell cycle slows down as
the cell number rises (Figure 1), because the shifting
It should be noted that overexpressing PDGF does not balance between PDGF supply and demand should cause
affect the final number of postmitotic, differentiated oli- the PDGF concentration to decrease with time. Finally,
godendrocytes that accumulates after birth [3], despite it explains why the ultimate rate of cell division is the
the increased number of progenitor cells. This is because same in normal mice and transgenic PDGF overexpressers
numbers of progenitors and oligodendrocytes are con- (Figure 4), as the PDGF concentration should be deter-
trolled separately, progenitors by the mitogenic effect of mined solely by the relative rates of PDGF supply and
PDGF and oligodendrocytes by axon-derived survival fac- consumption, which, according to the model, are always
tors [15]. Our previous experiments showed that the rate of equal at steady state.
oligodendrocyte production is elevated in NSE-PDGF-A
mice but that the excess oligodendrocytes are removed We tried to detect a decline in PDGF concentration
by programmed cell death, leaving a normal number of in vivo by Western blotting. We were unable, however,
mature, myelinating cells [3]. to detect PDGF-A in embryonic spinal cord tissue (E12 to
birth) from either wild-type or homozygous NSE-PDGF-A
We previously estimated the average progenitor cell cycle mice, using any of several antibodies against PDGF-A or
time at steady state (E17) to be about 24 hr [3]. To explain an antibody against the Myc tag on the carboxy terminus
how the cells could continue to divide once a day while of transgene-derived human PDGF-A (data not shown).
their number remained constant, we had to invoke large- We were also unable to detect PDGF-A by immunohisto-
scale death and removal of newly formed cells, around chemistry in spinal cord sections. In contrast, we were
200 cells per 10-mm section per day. The fact that we easily able to detect the product of another PDGF trans-
could not detect large numbers of dying oligodendrocyte gene encoding a nonsecreted form of PDGF-A that has
lineage cells in the prenatal spinal cord was not perceived an endoplasmic reticulum retention signal (KDEL) ap-
to be a problem, as dead cells are usually cleared rapidly. pended to its carboxy terminus, either by immunohisto-
Our revised cell cycle time of z100 hr at steady state, chemistry [3] or Western blot (data not shown). It is likely
however, means that the scale of oligodendrocyte death that PDGF is normally secreted rapidly after synthesis
in the prenatal spinal cord can now be revised downward and is difficult to detect once it leaves the cell. We have
to around 50 cells/section/day. in the past been able to detect PDGF immunoreactivity in
situ, but only inside cells, not in the extracellular space [16].
We do not understand why our previous estimates of cell
cycle time (Tc) were 4-fold shorter than they should have
We also tried to detect PDGF activity indirectly by visual-been. The measured labeling index (L) after a single
izing activated PDGFRa on Western blots of newbornBrdU pulse at E17 was similar then and now (z20%). We
spinal cord, using antibodies against both the receptorpreviously assumed an invariant S phase (Ts) of 4 hr;
and phosphotyrosine. Although we could easily detectgiven that it now seems that the S phase is closer to 12 hr
PDGFRa protein, we could not detect autophosphoryla-at E17 (Figure 1), this goes a long way toward explaining
tion. We could readily detect phosphorylated receptorsthe discrepancy at E17 (since Tc 5 Ts/L). It does not
on NIH 3T3 cells that were cultured in the presence ofexplain, however, the discrepancy at E13, when Ts <
10 ng/ml PDGF-AA. We tentatively conclude that the5 hr (Figure 1). We tried without success to replicate
level of receptor phosphorylation in oligodendrocyte pro-our previous results using both our present and former
genitors in vivo is low relative to PDGF-stimulated 3T3experimental paradigms. We conclude that, whatever the
cells, again consistent with our conclusion that the effec-source of error before, our present data are more reliable
tive PDGF concentration in vivo is very low.and should take precedence.
A mitogen depletion model of cell population growth It has been proposed before that dividing cells should
limit their own proliferation by consuming mitogens, onA simple explanation that fits our observations (though
not the only explanation; see Potential role of antiprolifer- the basis of mathematical modeling [17]. Moreover, Hol-
ley and Kiernan [18] showed that the final populationative factors, below) is that the proliferating cells limit
their own proliferation by consuming the available PDGF. density attained by fibroblasts in culture is proportional
to the initial serum concentration, and interpreted this inAs the cells multiply, the rate at which they consume
PDGF (by receptor binding and internalization) increases terms of depletion of serum growth factors by the ex-
panding cell population. This explanation is similar to,in proportion to cell number until the rate of consumption
matches the fixed rate of supply. At this point, increased and sets an early precedent for, the in vivo mitogen deple-
tion model we propose here.competition for PDGF prevents further proliferation. This
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Mitogen depletion could potentially explain other puz- is TGFb1 [24]. Thus, it is not unlikely that they produce
autocrine inhibitors of cell proliferation in vivo too, al-zling examples of cell number control. One example is
mouse aggregation chimeras. If two (or more) mouse blas- though TGFb1 itself does not seem to be important in this
context because we found that progenitor cell numbers aretocysts are aggregated in vitro and introduced into a surro-
gate mother, the chimeric blastocyst forms an oversized normal in newborn TGFb1 null mice (P.v.H., unpublished
embryo that implants into the uterine wall as normal. At data) [25]. TGFb family members have their own specific
the end of gestation, however, a normal-sized mouse is cell surface receptors and intracellular signaling pathways.
born. Size regulation occurs shortly after implantation, In some cells, under some conditions, (for example, fibro-
when there is a burst of rapid cell divisions that take the blasts cultured at a high cell density), TGFb1 can inhibit
embryo to a predetermined target size after which the the PDGF-mediated mitogenic response by a mechanism
cell cycle slows down again [19]. The cells of oversized involving PDGF receptor downregulation [26]. Other types
embryos divide less rapidly than normal during the post- of inhibitors that could in principle play an autocrine role
implantation burst, allowing them to reach the target size are PDGF binding proteins such as a2-microglobulin [27]
at the same time as their normal-sized littermates and or a receptor antagonist analogous to the Argos protein
develop in parallel thereafter [19]. This behavior could that inhibits epidermal growth factor signaling [28].
be explained if, for example, there were some invariant
population of cells at the implantation site that supplied The role of the intracellular clock that times
oligodendrocyte differentiationmitogens at a fixed rate, irrespective of the number of
There is known to be a cell-intrinsic mechanism thatcells in the embryo. The cells of the embryo would then
limits the proliferative lifetime of embryonic optic nerveregulate their own proliferation rate and population
oligodendrocyte progenitors cultured in vitro [29, 30].growth through competition for the limited mitogen sup-
This intracellular division limiter (clock) causes progeni-ply. Another example is that of tetraploid amphibians,
tor cells to lose responsiveness to PDGF, exit the cellwhich contain half the normal number of double-sized
cycle, and differentiate into oligodendrocytes after a fixedcells [20]. The larger cells of the tetraploid might be
time in vitro, even when they are cultured continuouslyexpected to carry more mitogen receptors than normal
in saturating concentrations of PDGF [31]. It is thoughtand to consume mitogens at a correspondingly faster rate.
that the primary function of the clock is to time the onsetTherefore, fewer cells should develop in the tetraploid
of oligodendrocyte differentiation around the time ofbefore mitogens are depleted and cell division arrests.
birth, but in principle it could also influence progenitor
cell number given that it stimulates cell cycle exit. Be-Potential role of antiproliferative factors
Formally, however, our data do not allow us to distinguish cause oligodendrocytes do not start to appear in large
numbers until after birth, however, the intracellular clockbetween mitogen depletion and autocrine production of
an antiproliferative agent(s). Both mechanisms would re- is unlikely to influence progenitor cell number noticeably
in the embryo although it might have a greater effect insult in a decrease in effective mitogenic activity that is
proportional to progenitor cell number. Antiproliferative the postnatal period. It might be possible to test this by
extending the kind of in vivo analysis described in thisfactors certainly do participate in developmental growth
control. For example, the TGFb superfamily member paper to postnatal ages.
NDF-8/myostatin negatively regulates muscle growth dur-
Conclusionsing development by inhibiting cell proliferation and myo-
First, for oligodendrocyte progenitors in the embryonicfibril growth [21, 22]. Myostatin is expressed by skeletal
spinal cord, we have shown that the cell cycle rate andmuscle cells, but it is not known whether it acts in an
final number of cells is tightly controlled by the mitogenicautocrine, paracrine, or systemic mode. Myostatin null
environment in the cord, with no obvious contributionmice have excessive skeletal muscle mass, whereas het-
from cell-intrinsic limits on cell proliferation. Second, toerozygous knockouts appear almost normal, suggesting
explain the strict proportionality between PDGF expres-that myostatin controls muscle growth in an all-or-nothing
sion and the steady-state number of progenitor cells, wefashion, not in a graded way as described here for PDGF.
suggest a simple mitogen depletion model, according toOne possibility is that myostatin normally inhibits muscle
which the cells limit their own proliferation by consuminggrowth through a step reduction in the sensitivity of mus-
the available mitogens. The expanding cell populationcle progenitors to mitogenic stimulation; mitogen deple-
consumes mitogens at an increasing rate until the rate oftion could still be the mechanism that ultimately halts
consumption matches the fixed rate of supply. As a result,muscle progenitor cell proliferation. In any case, mitogen
the mitogen concentration falls until it can no longer sup-depletion and autocrine inhibition are not mutually ex-
port proliferation. Other models are possible and mightclusive.
act in parallel. For example, the proliferating cells might
secrete an autocrine inhibitor of their own proliferation.Oligodendrocyte progenitors in culture are known to se-
crete self-inhibitory activity [23], one component of which The common feature of these models is that cells modify
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Figure 7 bearing cells were also NG-2 immunoreactive, and more than 95% of
NG-2-positive cells were PDGFRa positive.
BrdU labeling in vitro
Spinal cords were cultured as described previously [6], with PDGF-
AA (ImmunoKontact, Frankfurt, Germany) at various concentrations. In
mixed-age cultures, cells of one age were marked before mixing by
incubating in 1 mM carboxyfluorescein diacetate, succinimidyl ester
(CFSE, Molecular Probes) in the dark at room temperature, followed by
thorough washing. The stock was 1 mM CFSE in dimethyl sulfoxide.
After culturing overnight, 10 mM BrdU was added and the incubation
was continued at 378C. Coverslips were removed at various times and
the BrdU labeling index was determined as above.
Cell cycle analysis by cumulative BrdU labeling
For a uniformly cycling population of cells exposed continuously to BrdU,
the fraction of BrdU-labeled cells (labeling index, L) increases linearly
with time until all cells are labeled (L 5 1). By plotting L versus time of
BrdU exposure, the total cell cycle time (Tc) and S phase time (Ts) can
be deduced by the formulae (Tc 5 1/m) and (Ts 5 n/m), where m is
the gradient and n is the intercept on the L axis (that is, the labelingPDGFRa mRNA provides an accurate reflection of PDGFRa-positive
progenitor cell number. PDGFRa transcripts in the spinal cords of index after a single short pulse of BrdU) [32].
newborn mice of the indicated genotypes were measured by RNase
protection. PDGFRa mRNA abundance was plotted against We calculated the line of best fit and standard errors for m and n by
progenitor cell number counted directly from spinal cord sections (data the method of least squares, then the 67% confidence intervals (pm and
not shown). There is a linear relationship (correlation coefficient pn) by multiplying the standard errors by the t value of the two-tailed
R 5 0.99). Student’s t distribution for probability 0.33 (N-2 degrees of freedom)
[35]. From these, we calculated the corresponding 67% confidence
intervals for Tc and Ts. Because Tc and Ts are calculated from the
reciprocal of m, the confidence intervals are not symmetrical about the
mean, but for convenience, we quote the experimental errors for Tc andthe mitogenic properties of their environment at a rate Ts as 6 half the full range. Each cumulative labeling experiment was
proportional to the total number of cells in the population. repeated at least twice with similar results. One representative experi-
ment is shown in each case.
Materials and methods
Transgenic miceBrdU labeling in vivo Production and genotyping of transgenic NSE-PDGF-A mice and
An osmotic minipump (Alza Corporation; 1 ml/hr delivery rate) containing PDGF-A knockout mice has been described [8]. NSE-PDGF-A linesBrdU (180 mg/ml in 1% (w/v) ammonia solution) was inserted subcutane-
#75 and #82 can be distinguished on Southern blots by the differentously into a pregnant mouse to deliver BrdU at z180 mg/hr. Thus, it
sizes of junction fragments produced by BamHI digestion of genomictakes over 8 hr to deliver the same amount of BrdU as would a single
DNA. To distinguish hemizygous and homozygous transgenics, bandinjection at the usual dose of 50 mg BrdU per gram body weight (around
intensity was quantified using a phosphoimager (Packard). To generate30 g for a pregnant female). The latter method of delivery has been
offspring with different combinations of transgene loci (for Figure 5), weshown to be nontoxic for neurons in the developing cerebral cortex at
crossed male and female double-hemizygous 75,82/1,1 mice.E14 [32]. To determine whether our labeling regimen was adequate to
visualize all dividing cells, we compared the BrdU labeling index of
Tissue preparation and in situ hybridizationprogenitors after the implantation of either one or three minipumps. With
Tissue preparation and in situ hybridization was done as describedthree pumps the BrdU-labeled cells appeared brighter, but the calculated
previously [11]. Cryosections were cut at a 10-mm nominal thickness.labeling index was unchanged.
The PDGF-A antisense probe was transcribed from a 68-bp EcoRI-
HindIII fragment encompassing most of the human PDGF-A cDNA [36]After labeling, embryonic or pup spinal cords were dissected, and disso-
cloned into pBluescript-SK (Stratagene). The plasmid was linearizedciated cells cultured overnight in a defined medium [33] as described
with EcoRI and transcribed with T7 RNA polymerase (T7pol). Thepreviously [6]. Omitting thyroxine and triiodothyronine from the medium
PDGFRa probe was transcribed from a 1636-bp EcoRI fragment encod-in control experiments (data not shown) had no significant effect on cell
ing most of the extracellular domain of mouse PDGFRa [37] cloned intocycle kinetics, and therefore the fully supplemented medium was used
pBluescript-KS. The plasmid was linearized with HindIII and transcribedfor all experiments reported here. Coverslips were labeled with anti-NG2
with T7pol. In some experiments, PDGFRa-positive progenitors werechondroitin sulfate proteoglycan (Chemicon International) and anti-BrdU
counted in high-magnification photographic prints of in situ hybridization(monoclonal BU209) [34] followed by the appropriate fluorescein- or
micrographs.rhodamine-conjugated secondary antibodies. Labeled cells were counted
in a fluorescence microscope and the labeling index (the fraction of
RNase protection assayNG2-positive oligodendrocyte progenitors that was also BrdU positive)
mRNA expression was analyzed by RNase protection [38] using thewas calculated. For each time point, at least 200 NG2-positive cells on
cDNAs described above for the preparation of 32P-labeled riboprobes.each of three or more coverslips were scored. Alternatively, spinal cord
Protected RNA fragments were separated on a 6% (w/v) polyacrylamide-sections were subjected to combined BrdU immunohistochemistry and
sequencing gel. Band intensities were measured using a phosphoimagerin situ hybridization with a probe against mouse PDGFRa to identify
and, after background subtraction, each value was normalized againstlabeled oligodendrocyte progenitors. Both methods yielded similar label-
mRNA levels for the housekeeping gene GAPDH. A control experimenting indices at E13, so immunolabeling of dissociated cells was used in
showed that PDGFRa mRNA abundance gives an accurate reflectionall further experiments. Control experiments (data not shown) confirmed
that, in spinal cord cultures, 100% of PDGFRa-immunoreactive process- of oligodendrocyte progenitor cell number (Figure 7).
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